Cyclic peptide inhibitors of phosphatidylinositol 3-kinase p85 SH2 domain binding. 1994

T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
Laboratory of Medicinal Chemistry, NCI, National Institutes of Health, Bethesda, MD 20892.

Cyclic hexameric peptides based on the amino acid sequence "Gly-Xxx-Val-Pro-Met-Leu", where Xxx is either phosphotyrosyl (pTyr) residue or a hydrolytically stable pTyr mimetic, were examined for their ability to bind to the C-terminal SH2 domain of the p85 phosphoinositol 3-kinase (PI 3-kinase). The cyclic peptides retained significant binding affinity relative to their linear counterparts. Potency varied depending on Xxx in the order: phosphonomethyl phenylalanine (Pmp, ID50 = 5.2 microM) < phosphonodifluoromethyl phenylalanine (F2Pmp, ID50 = 2.2 microM) < pTyr (ID50 = 1.0 microM), with Xxx = Tyr being inactive (ID50 > 500 M). Greatly reduced potency was observed when Xxx was of the unnatural D-configuration. The cyclic peptides represent conformationally constrained ligands which should be useful in the development of p85 SH2 domain-directed inhibitors.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017853 Phosphotransferases (Alcohol Group Acceptor) A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.
D019869 Phosphatidylinositol 3-Kinases Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositol to 1-phosphatidylinositol 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell. PI-3 Kinase,Phosphatidylinositol-3-OH Kinase,PtdIns 3-Kinase,PI 3-Kinase,PI-3K,PI3 Kinases,PI3-Kinase,Phosphoinositide 3 Kinases,Phosphoinositide 3-Hydroxykinase,PtdIns 3-Kinases,3-Hydroxykinase, Phosphoinositide,Kinase, PI-3,Kinase, Phosphatidylinositol-3-OH,Kinases, PI3,Kinases, Phosphoinositide 3,PI 3 Kinase,PI3 Kinase,Phosphatidylinositol 3 Kinases,Phosphatidylinositol 3 OH Kinase,Phosphoinositide 3 Hydroxykinase,PtdIns 3 Kinase,PtdIns 3 Kinases

Related Publications

T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
April 1993, Biochemistry,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
August 1992, Nature,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
July 1996, The EMBO journal,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
March 1992, Molecular and cellular biology,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
March 2001, Genes & development,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
March 1994, Science (New York, N.Y.),
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
June 1992, The Journal of biological chemistry,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
September 1994, Molecular and cellular biology,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
May 1993, Cell,
T R Burke, and M Nomizu, and A Otaka, and M S Smyth, and P P Roller, and R D Case, and G Wolf, and S E Shoelson
April 1996, Nature structural biology,
Copied contents to your clipboard!